BeStock  

Bristol-Myers Squibb BMY

US equityMarket cap rank #158Cancer Research
$61.83 −$0.31 (-0.49%)
Market open · Nov 10, 9:40 am ET · After hours $62.43 +0.47%
Open$61.75
Prev close$62.14
Day range$61.42 – $62.13
Volume274.5K
Market cap$126.40B
P/E (TTM)13.7
Dividend yield4.08%

Dividends

Dividend yield (TTM)4.08%
Last dividend$0.63Ex-date 2 Oct 2026
Next-to-last$0.63
Payments on file40

Repeating the last declared payment 4 times a year (its usual pace) works out to a forward annual dividend of $2.52, a 4.08% forward yield at today’s price.

Dividends paid per share, by year

1.5620171.6020181.6420192.2920202.1620222.2820232.4020242.482025

Across the full calendar years shown, the annual payout grew by roughly 6.8% a year.

The payout has held steady or grown for 4 straight full years on file.

Ex-datePay dateAmount
2 Oct 2026 2 Nov 2026 $0.63
2 Jul 2026 3 Aug 2026 $0.63
2 Apr 2026 1 May 2026 $0.63
2 Jan 2026 2 Feb 2026 $0.63
3 Oct 2025 3 Nov 2025 $0.62
3 Jul 2025 1 Aug 2025 $0.62
4 Apr 2025 1 May 2025 $0.62
3 Jan 2025 3 Feb 2025 $0.62
4 Oct 2024 1 Nov 2024 $0.60
5 Jul 2024 1 Aug 2024 $0.60
4 Apr 2024 1 May 2024 $0.60
4 Jan 2024 1 Feb 2024 $0.60
5 Oct 2023 1 Nov 2023 $0.57
6 Jul 2023 1 Aug 2023 $0.57
6 Apr 2023 1 May 2023 $0.57
5 Jan 2023 1 Feb 2023 $0.57
6 Oct 2022 1 Nov 2022 $0.54
30 Jun 2022 1 Aug 2022 $0.54
31 Mar 2022 2 May 2022 $0.54
6 Jan 2022 1 Feb 2022 $0.54
30 Sep 2021 1 Nov 2021 $0.49
1 Jul 2021 2 Aug 2021 $0.49
31 Mar 2021 3 May 2021 $0.49
31 Dec 2020 1 Feb 2021 $0.49
1 Oct 2020 2 Nov 2020 $0.45
2 Jul 2020 3 Aug 2020 $0.45
2 Apr 2020 1 May 2020 $0.45
2 Jan 2020 3 Feb 2020 $0.45
3 Oct 2019 1 Nov 2019 $0.41
3 Jul 2019 1 Aug 2019 $0.41
4 Apr 2019 1 May 2019 $0.41
3 Jan 2019 1 Feb 2019 $0.41
4 Oct 2018 1 Nov 2018 $0.40
5 Jul 2018 1 Aug 2018 $0.40
5 Apr 2018 1 May 2018 $0.40
4 Jan 2018 1 Feb 2018 $0.40
5 Oct 2017 1 Nov 2017 $0.39
5 Jul 2017 1 Aug 2017 $0.39
5 Apr 2017 1 May 2017 $0.39
4 Jan 2017 1 Feb 2017 $0.39

Stock splits

Effective dateRatio
1 Mar 19991→2:1

Discussion

No comments yet — be the first to weigh in on BMY.

Sign in to join the discussion.

Scroll to Top